Literature DB >> 1849211

Primary undifferentiated small cell carcinoma of the esophagus: clinicopathological and flow cytometric evaluation of eight cases.

J Isolauri1, J Mattila, O P Kallioniemi.   

Abstract

We present a clinicopathological and flow cytometric evaluation of eight primary small cell carcinomas of the esophagus representing 1.5% of all esophageal malignancies diagnosed during a 22-year period (1965-1987) in the Tampere University Central Hospital. The mean age of the patients (four male and four female) was 67 years (range 55-75 years). Five cases had distant metastases at the time of diagnosis. Three patients were treated by esophageal resection, one by laser vaporisation, and four by chemotherapy. The median survival time was 4 months (range 9 days to 8 months). A complete local response to chemotherapy in serial esophagogramms was detected in one patient. All four patients given chemotherapy survived longer than those treated with esophageal resection only. Four (67%) of the six carcinomas analyzed by DNA flow cytometry contained DNA-aneuploid stemlines. The median S-phase fraction of these small cell carcinomas was high (16.3%), reflecting rapid cell proliferation rate, which may be related to their responsiveness to chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849211     DOI: 10.1002/jso.2930460310

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

1.  Small cell carcinoma of the esophagus responding to fourth-line chemotherapy with weekly paclitaxel.

Authors:  Masaki Matsuoka; Narikazu Boku; Takayuki Yoshino; Shuichi Hironaka; Yusuke Onozawa; Akira Fukutomi; Sadamoto Zenda; Kentaro Yamazaki; Hirofumi Yasui; Noriaki Hasuike; Tetsuya Inui; Yuichiro Yamaguchi; Hiroyuki Ono; Minoru Kamata
Journal:  Int J Clin Oncol       Date:  2005-12       Impact factor: 3.402

2.  Primary small cell carcinoma of the esophagus: report of a case.

Authors:  I Muto; T Nishimaki; K Aizawa; T Suzuki; O Tanaka; K Hatakeyama
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

Review 3.  Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.

Authors:  Günter Klöppel; Guido Rindi; Martin Anlauf; Aurel Perren; Paul Komminoth
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

4.  Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases.

Authors:  Jing-Ping Yun; Mei-Fang Zhang; Jin-Hui Hou; Qiu-Hong Tian; Jia Fu; Xiao-Man Liang; Qiu-Liang Wu; Tie-Hua Rong
Journal:  BMC Cancer       Date:  2007-03-03       Impact factor: 4.430

5.  The 2002 AJCC TNM classification is a better predictor of primary small cell esophageal carcinoma outcome than the VALSG staging system.

Authors:  Sheng-Ye Wang; Wei-Ming Mao; Xiang-Hui Du; Ya-Ping Xu; Su-Zhan Zhang
Journal:  Chin J Cancer       Date:  2012-10-10

6.  Adjuvant Therapeutic Modalities in Primary Small Cell Carcinoma of Esophagus Patients: A Retrospective Cohort Study of Multicenter Clinical Outcomes.

Authors:  Bingwen Zou; Tao Li; Qiang Zhou; Daiyuan Ma; Yongshun Chen; Meijuan Huang; Feng Peng; Yong Xu; Jiang Zhu; Zhenyu Ding; Lin Zhou; Jin Wang; Li Ren; Min Yu; Youling Gong; Yanying Li; Longqi Chen; You Lu
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.